Do you want to read an article? Please log in or register.
Ozone-Based Eye Drops Activity on Ocular Epithelial Cells and Potential Pathogens Infecting the Front of the Eye
Cornea and Corneal DiseasesFurther Publications
Related content
COMMENTED
Glaucoma and Ocular Pressure
Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
Lancet.
Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C,
Wormald R, Nathwani N, Barton K, Rubin G, Buszewicz M, LiGHT Trial Study Group
doi: 10.1016/S0140-6736(18)32213-X.
Glaucoma and Ocular Pressure
Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis
Br J Ophthalmol.
Hedengran A, Steensberg AT, Virgili G, Azuara-Blanco A, Kolko M
doi: 10.1136/bjophthalmol-2019-315623.
Glaucoma and Ocular Pressure
Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016
Acta Ophthalmol.
Chamard C, Larrieu S, Baudouin C, Bron A, Villain M, Daien V
doi: 10.1111/aos.14410.
Cornea and Corneal DiseasesRetinal Diseases
Ocular Biomarkers of Alzheimer's Disease: The Role of Anterior Eye and Potential Future Directions
Invest Ophthalmol Vis Sci.
Dehghani C, Frost S, Jayasena R, Masters CL, Kanagasingam Y
doi: 10.1167/iovs.18-24694.
Retinal Diseases
Pathogenesis of ocular toxoplasmosis.
Prog Retin Eye Res
Smith JR, Ashander LM, Arruda SL, Cordeiro CA, Lie S, Rochet E, Belfort R, Furtado JM
doi: 10.1016/j.preteyeres.2020.100882
Retinal Diseases
Pathogenesis of ocular toxoplasmosis
Prog Retin Eye Res.
Smith JR, Ashander LM, Arruda SL, Cordeiro CA, Lie S, Rochet E, Belfort R, Furtado JM
doi: 10.1016/j.preteyeres.2020.100882.
Glaucoma and Ocular PressureOcular OncologyRetinal Diseases
Nanotechnology-based strategies for treatment of ocular disease
Acta Pharm Sin B.
Weng Y, Liu J, Jin S, Guo W, Liang X, Hu Z
doi: 10.1016/j.apsb.2016.09.001.
RECOMMENDED
Further Publications
The eye as the discrete but defensible portal of coronavirus infection
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
doi: 10.1016/j.jtos.2020.05.011.
Cornea and Corneal Diseases
Argon cold plasma - a novel tool to treat therapy-resistant corneal infections
Am J Ophthalmol.
Reitberger HH, Czugala M, Chow C, Mohr A, Burkovski A, Gruenert AK, Schoenebeck R, Fuchsluger TA
doi: 10.1016/j.ajo.2018.03.025.